The number of Americans filing for unemployment benefits fell last week, but signs of a weaker labour market continue to emerge as both hiring and worker supply ease. Initial claims for state unemployment benefits dropped by 33,000 to a seasonally adjusted 231,000 for the week ending September 13, the Labor Department reported on Thursday. ...

Nvidia Corp. (NASDAQ: NVDA) has nearly lost access to the Chinese market in the recent past. ...

By some counts, there are over 100 electric vehicle (EV) companies in China. People who watch the industry closely believe that only a very small number will survive. ...

Group 1 - Nike stock advanced early Thursday due to an upgrade and price target hike from RBC Capital, which upgraded the stock to outperform from sector perform [1] - RBC Capital anticipates a "steeper revenue recovery" for Nike compared to most Wall Street estimates, attributing this to new product contributions and sales [1] - The sporting goods company also owns slower-growing brands such as Wilson and Louisville Slugger [2]

It’s no secret that electric-vehicle manufacturer Lucid Group (LCID) is a mess. Sure, since hitting an apparent near-term bottom on Sept. 4, LCID stock has jumped 26%. But that’s not going to get rid of the bad taste stemming from the year-to-date loss of roughly 33%. What’s more, in the trailing five years, LCID has stumbled over 79%. When Lucid first entered the EV fray, it potentially offered viable competition to Tesla (TSLA). While the latter had become synonymous with next-generation mobility, its v ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Group 1 - Intuitive Surgical (NASDAQ: ISRG) is transforming the healthcare industry with its surgical systems, enhancing the ability of surgeons to perform complex surgeries and improving patient outcomes [1] - Despite its long-term potential, Intuitive's stock has faced challenges, declining by 14% this year and reaching a 52-week low of $425 [2] - The company is exploring telesurgery, which allows surgeons to collaborate remotely, potentially revolutionizing access to surgical care [3][4] Group 2 - The telesurgery market was valued at $2 billion in 2023 and is projected to grow to nearly $6 billion by the end of the decade, driven by advancements in AI and efficiency [5] - Intuitive's surgical systems, including the da Vinci 5, are expensive but have shown significant growth in operations and profitability, outpacing earnings growth over the past five years [6] - The company's systems are positioned to advance healthcare and make telesurgery a viable option for patients, indicating promising long-term prospects [7]

Core Insights - Alnylam Pharmaceuticals has joined the Alliance for Genomic Discovery (AGD), which aims to accelerate drug discovery through clinical genomic data [1][2][3] - The AGD dataset will enhance Alnylam's ability to identify new therapeutic targets for RNA interference (RNAi) therapeutics, which work by silencing disease-causing genes [4][5] - The AGD now includes nine members, with Alnylam being the latest addition, and plans to expand its dataset by sequencing an additional 31,250 whole genomes, building on an existing cohort of 250,000 [3][5] Company and Industry Developments - The AGD is led by Illumina and Nashville Biosciences, focusing on leveraging genomic data to drive innovation in therapeutics [2][3] - Alnylam's participation is expected to strengthen the AGD's clinical genomic database, which aims to provide diverse and representative data for drug discovery [5][6] - The alliance has already identified novel therapeutic targets, particularly in autoimmune and neurodegenerative diseases, demonstrating the dataset's value to its members [6][8] Technological Advancements - The AGD utilizes advanced sequencing and data analysis technologies, such as DRAGEN and Illumina Connected Analytics, to enhance the accuracy and speed of genomic insights [6][8] - The alliance plans to incorporate multiomic layers into its dataset, which will facilitate faster target discovery and therapy development [8] - The AGD dataset aims to link diverse genomic data with clinical phenotyping to ensure that discoveries benefit a wide range of populations [5][6]

VANCOUVER, BRITISH COLUMBIA – TheNewswire - September 18, 2025 – PRISMA EXPLORATION INC. (CSE: PMS) (“Prisma” or the "Company") is pleased to announce that the Company’s name will formally change from “Prisma Exploration Inc.” to “Grafton Resources Inc.” on September 22, 2025. The Company’s common shares will begin trading on the Canadian Securities Exchange on September 25, 2025 under the new name and the trading symbol for the Company will change from “PMS” to “GFT”.  The new CUSIP will be 38447A108 and t ...

WILMINGTON, Del.--(BUSINESS WIRE)--WSFS Financial Corporation (Nasdaq: WSFS), the parent company of Bryn Mawr Trust, announced today a series of key leadership appointments within its wealth management division, reinforcing its commitment to growth and talent, while aligning with the strategic goal to increase wealth fee revenue by 50% in the three-year period ending in 2027. Michael Mendelson has joined Bryn Mawr Trust as Senior Vice President, Chief Operating Officer. In this role, he will be. ...